Company Search:
Advanced Search
Sponsored Links
Clovis Oncology Inc Company Snapshot
Clovis Oncology Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Clovis Oncology Inc with three other companies in this sector in the United States: Sunwin Stevia International Incorporation (2014 sales of $12.87 million of which 81% was Stevioside), BioSpecifics Technologies Corp. ($14.08 million of which 100% was Pharmaceutical Products), and Chiasma Inc ($13.17 million of which 100% was Pharmaceutical).

Sales Analysis.
  Stock Performance Chart for Clovis Oncology Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 55.46
(Figures in U.S. Dollars)
1 Week 20.5%   13 Weeks 49.1%  
4 Weeks 74.3%   52 Weeks 146.3%  
Clovis Oncology Inc Key Data:
  Ticker: CLVS Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2014 Sales 13,625,000
(Year Ending Jan 2015).
Employees: 309
  Currency: U.S. Dollars Market Cap: 2,139,960,815
  Fiscal Yr Ends: December Shares Outstanding: 38,585,662
  Share Type: Common Closely Held Shares: 1,721,377
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.